IMARC Group’s report titled “Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the global wearable injectors market share. The global market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.6 Billion by 2028, exhibiting a growth rate (CAGR) of 14.8% during 2023-2028.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/wearable-injectors-market/requestsample
Factors Affecting the Growth of the Wearable Injectors Industry:
- Rising Prevalence of Chronic Diseases:
The escalating demand for wearable injectors due to the increasing prevalence of chronic conditions like diabetes, autoimmune diseases, and cardiovascular ailments among the masses around the world is supporting the growth of the market. In line with this, wearable injectors offer a convenient solution for patients, ensuring timely and accurate administration of medications without the need for frequent clinic visits. Besides this, these devices provide an efficient way to manage chronic diseases, improve treatment adherence, and enhance overall patient outcomes.
- Technological Advancements:
Innovations in wearable injector technology, such as miniaturization, improved user interface, and connectivity features, are contributing to the growth of the market. These innovations enhance device usability, safety, and patient experience, leading to increased acceptance among healthcare providers and patients. Moreover, features like dose monitoring, automatic injection, and integration with smartphone apps for data tracking further enhance device functionality, promoting their adoption in the healthcare ecosystem. Apart from this, needle-free wearable injectors utilize alternative methods, such as microjets or high-pressure gas, to deliver medications through the skin without the use of needles. These systems offer painless and minimally invasive (MI) drug delivery.
- Patient Preferences for Self-Administration:
The growing adoption of wearable injectors on account of rising preferences for self-administration among patients is offering a positive market outlook. In addition, the increasing focus on patient-centered care is bolstering the market growth. Wearable injectors empower patients to take control of their healthcare by enabling convenient and on-the-go medication delivery. This enhances patient satisfaction, improves treatment adherence, and reduces healthcare burdens associated with traditional clinic-based injections. Besides this, patients are seeking greater flexibility and independence in managing their health.
Leading Companies Operating in the Global Wearable Injectors Industry:
- Becton Dickinson and Company
- CeQur SA, Debiotech SA
- Dexcom Inc.
- Enable Injections Inc.
- Gerresheimer AG
- Insulet Corporation
- Tandem Diabetes Care Inc.
- West Pharmaceutical Services Inc
- Ypsomed AG
Wearable Injectors Market Report Segmentation:
By Type:
- On-body
- Off-body
On-body represents the largest segment, which can be accredited to its ability to offer enhanced convenience to patients.
By Technology:
- Spring-based
- Motor-driven
- Rotary Pump
- Expanding Battery
- Others
Spring-based holds the biggest market share as it is a simple and reliable mechanism for drug delivery.
By Application:
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Others
Oncology accounts for the largest market share due to the rising need for continuous drug delivery.
By End Use:
- Hospitals and Clinics
- Home Care
- Others
Home care exhibits a clear dominance in the market on account of the increasing number of the geriatric population.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys a leading position in the wearable injectors market, which can be attributed to the highly developed healthcare infrastructure with advanced medical facilities.
Global Wearable Injectors Market Trends:
The increasing need for more efficient healthcare delivery systems among individuals is bolstering the market growth. In addition, wearable injectors offer cost-effective solutions by reducing hospital admissions, clinic visits, and healthcare resource utilization associated with traditional injection methods.
Furthermore, the rising focus on home-based healthcare and remote patient monitoring is propelling the market growth. Wearable injectors play a crucial role in enabling patients to manage their conditions outside traditional clinical settings. They facilitate home-based healthcare, enabling patients to receive treatment in familiar environments while minimizing healthcare costs. They also offer various benefits, such as improved medication adherence, reduced pain and discomfort associated with injections, precise dosing, and minimized needle anxiety.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
